Share Your Research, Maximize Your Social Impacts
Lipid-lowering, cardiovascular and anti-inflammatory effects of ?Letium? in patients with hypertension
Journal: Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini (Vol.1, No. 1)Publication Date: 2014-12-12
Authors : M.N. Kochueva; A.N. Korzh; G.I. Kochuev; V.A. Gavriluk; O.A. Plehova;
Page : 78-85
Keywords : Hypertension; C-reactive protein; lipid lowering therapy; endothelium vasodilatation;
Source : Download
Find it from : Google Scholar
Abstract
This paper studied the dynamics of the lipid spectrum of blood and functional state of the endothelium of blood C-reactive protein (CRP) in patients with hypertension stage 1-2, which were additional factors of cardiovascular risk, under the influence of adjuvant therapy with the use of the drug Letium. 12-week therapy with the inclusion of Letium was accompanied by a statistically significant reduction in plasma total cholesterol, total TG, LDL cholesterol, atherogenic factor and increased levels of anti atherogenic HDL cholesterol.
Other Latest Articles
- Variability of blood pressure and autonomic homeostasis status of patients with arterial hypertension in the dynamic of treatment by a drug ?Neotenz?
- Urinalysis in general therapeutic practice
- Thyroid dysfunction and pregnancy: common grounds, the mechanisms of realization, management tactics
- Calcium channel blockers: of action and peculiarities clinical usage
- Neuroendocrine mechanisms of development of nephropathy of patients with an essential hypertension and obesity
Last modified: 2016-06-25 06:41:52